IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abingworth LLP

Q3 2021 Holdings

Filed 2021-11-15 | 20 holdings | $440.7K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Vaxcyte(PCVX)Common92243G108$105.8K4,168,71824.0%
eFFECTORCommon28202V108$67.0K4,822,11415.2%
JasperCommon471871103$58.0K5,628,55813.2%
Vera(VERA)Common92337R101$51.4K2,960,23111.7%
Phathom(PHAT)Common71722W107$38.5K1,203,1358.7%
Sierra OncologyCommon82640U107$19.0K876,6564.3%
Reneo(RPHM)Common75974E103$15.3K2,073,9573.5%
SientraCommon82621J105$13.5K2,349,8273.1%
Verona(VRNA)SPONDS ADR925050106$13.4K2,457,4993.0%
Adicet(TORCEUR)Common007002108$12.6K1,615,3852.9%
Spruce BioCommonE5209E109$10.7K1,792,5182.4%
SolenoCommon834203200$9.5K10,302,6022.2%
NucanaADR67022C106$8.6K3,333,3331.9%
Exicure(XCUR)Common30205M101$8.2K6,977,0001.9%
ParatekCommon699374302$5.1K1,041,1311.1%
Aeglea(AGLEUSD)Common00773J103$1.9K240,5000.4%
Molecular TemplatesCommon608550109$1.3K200,0000.3%
Cymabay(CBAYUSD)Common23257D103$478131,0360.1%
ObsevaCommonH5861P103$27487,9990.1%
OcugenCommon43358V109$517,1110.0%